Approval · Notice of Compliance 2618 · 2001
TAMONE: Notice of Compliance 2618
Issued December 28, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2618
- Date
- December 28, 2001
- Company
- Pharmacia Canada Inc.Baie D'Urfe, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antineoplastic agent
Products in this notice
Medicinal ingredients
- TAMOXIFEN CITRATE 10 MG per TAB
- TAMOXIFEN CITRATE 20 MG per TAB